On infectious disease outbreaks, healthcare regulation, mental health, preventive health, and more
Time and time again as we celebrate achievements in health care, a measurable pinnacle of which could be the Nobel for Physiology/ Medicine, a sobering dose indicating the power of pathogen is delivered to us. This time, with the reported case of all things, the plague, in Russia. This week we discovered that the entire issue is mired in mystery, with not much information being shared by the nation. What was clear during the COVI-19 pandemic was the absolute criticality of sharing information globally, but with every squeak about the break out of infectious disease. In fact the Pandemic Agreement includes an aspect of Pathogen Sharing and Benefits among member nations. However, practically, sometimes nations find it difficult to easily share information with the global community.
Initially, the WHO cited initial, unconfirmed reports suggesting pneumonic plague, a severe disease less common than the better-known bubonic plague linked to the Black Death in the Middle Ages. A WHOOfficial said the global organisation doesn’t know exactly how lab worker in Russia died in plague case. Maria Van Kerkhove, WHO director of Epidemic and Pandemic Management, said the agency doesn’t know the “causative agent” behind the woman’s October 2 death, and urged Russia to share more information. The EU also urged Russia to be ‘transparent’ on plague reports - The Hindu
On its part, in tersely-worded statements, Russia’s public health watchdog, Rospotrebnadzor, does not link the case to pneumonic plague, maintaining that “extensive” testing found no evidence the lab worker’s illness was caused by any of the pathogens she worked with at the Irkutsk Anti-Plague Research Institute of Siberia and the Far East. Russia earlier said she died of pneumonia — a “typical” acute respiratory viral infection — and its health authorities have found no cases of plague recently. Moscow also denied sanitary measures over plague reports.
For an idea of what we actually know for sure now, do read this explainer: Pneumonic plague outbreak in Russia?
In addition, there was a fresh scare from Ebola-affected Africa: Kenya confirms first Ebola case imported from Congo after patient dies in Nairobi. Why is this significant? I explain here: Ebola death recorded in Kenya after victim travelled from DRC. The victim had been living in DRC for years, and was reportedly already ill before he took a road trip, and then, a flight back home to Nigeria. He was admitted to a hospital in Nigeria by a relative, but succumbed to his illness. This is the first case of an Ebola death that has occurred in a country, outside of the DRC and Uganda, during the outbreak raising significant concern regarding transmissibility for public health authorities. Kenyan authorities have called for stricter controls at the airports and also undertaken efforts to spread awareness and urge citizens to test if they notice symptoms. While the WHO has not issued a travel ban to the affected countries, self declaration by travellers has become mandatory at all international ports.
The past week also saw some hectic health-related activity in India. The most significant among them was easily the Supreme Court calling for a cap on trade margin for all essential medicines and medical products, as Aaratrika Bhaumik reported. As the government declared that it had proposed a 30% trade-margin cap on patented and non-patented cancer medicines, but top court asks why a margin cap cannot be extended to all medicines and medical products; the court says the government has to ensure that DPCO-approved medicines, whose price is legally regulated, reach patients. That is jumping the gun though, first read Bindu Shajan Perappadan’s article: Centre to cap trade margins on non-scheduled cancer drugs to 30% of MRP.
She also reported on the Centre’s direction to the States toDisplay rates of healthcare services prominently. Clearly visible display will enable patients to take informed decisions, build trust, prevent billing-related disputes; the Health Ministry also urged clinical establishments to display package rates for international patients visiting India on medical and Ayush visas. Another significant decision taken in the country last week: NMC brings doctors’ digital patient acquisition under ethics rules. In regulatory terms, the Centre proposing tighter curbs on advertising of prescription drugs was also a development of note.
Moving on to mental health issues, Afshan Yasmeen reported a NIMHANS study that found loneliness linked to psychological distress, excessive series watching among parents of children who had emigrated.The study examined 64 ‘empty-nest’ parents aged between 45 and 65, whose adult children had emigrated and lived away from home for at least two years.
Athira Elssa Johnson wrote on Treatment-resistant depression and what happens when antidepressants do not work, while Dr. Sowjanya Gunukula took us through Dental anxiety, particularly important, because here, fear becomes a barrier to care.
Looking at the Indian health care system and the larger stage, Rajendra Pratap Gupta argues that to retain and grow its advantage, India needs a smarter healthcare margin policy, explaining the role of MRP in the sale of drugs and health care consumables. A lesson or two here for India’s drug price regulators, surely.
K. VijayRaghavan and Archish Mittal discuss how Indian research can shape the worldwhile Priyadarshini Singh reemphasisesIndia’s stakes in the Global Pandemic Agreement
And more…
Zubeda Hamid on the In Focus podcast, discusses the fact thatNew research has linked 12% of cancer cases to infections
Dr. Priya Chockalingam writes on Why it is essential to improve cardiac rehabilitation completion rates in India - The Hindu
Further in our explainer series, there iscoronary thrombosis, Epstein-Barr virus, stem-cell donor registries and how they work
The Hindu’s editorial on breaking the chain in leprosy in India
And before we sign off, we leave you with a link to our Health Wrap episode from last Sunday, where we discuss the 2026 Nobel Prize, brain research, and healthcare access.
(There is much more, do head to ourhealth pageand subscribe to the health newsletterhere)